The AIPSS-MDS model is an enhancement of the AIPSS-MDS score, incorporating molecular data from the molecular IPSS cohort (Bernard et al. 2022).
Age
Sex
Hemoglobin (g/dL)
Leukocytes (10^9/L)
Platelets (10^9/L)
Bone Marrow Blasts (%)
Neutrophils (%)
Cytogenetic Group
The risk bar graphically represents a patient's risk level as a percentile, ranging from 0 to 100. A score of 0 signifies minimum risk, while 100 represents maximum risk. Visually, the bar evolves in color from green denotes low risk to red signifies high risk. This percentile and color-coded system provides an immediate, intuitive understanding of how a patient's risk compares to the broader population, assisting in informed medical decision-making.
The app features interactive plots that offer a range of functionalities for enhanced data analysis. You can zoom in for a closer look, navigate through the plot to obtain precise X-Y values, and download data files.
Mosquera Orgueira A, Perez Encinas MM, Diaz Varela NA, Mora E, Díaz-Beyá M, Montoro MJ, Pomares H, Ramos F, Tormo M, Jerez A, Nomdedeu JF, De Miguel Sanchez C, Leonor A, Cárcel P, Cedena Romero MT, Xicoy B, Rivero E, Del Orbe Barreto RA, Diez-Campelo M, Benlloch LE, Crucitti D, Valcárcel D. Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes. Hemasphere. 2023 Oct 11;7(10):e961. doi: 10.1097/HS9.0000000000000961. PMID: 37841754; PMCID: PMC10569758.